Remote CNS Account Specialist for Launch & Access

Praxis Precision Medicines, Inc.; Ann Arbor, Northern (MI, KY); Hybrid; USD 160,000 - 192,000; Full time

Job summary

Praxis Precision Medicines, Inc. is seeking six Account Specialists to cover the Ann Arbor Region in a remote US role.

Successful candidates will engage healthcare providers, support launches, and drive access to our CNS-focused therapies across the territory. You will collaborate with Market Access, Patient Services, and Medical teams to optimize patient outcomes, navigate complex access pathways, and deliver on commercial objectives while maintaining extensive product and disease-state

Qualifications

• 5+ years direct sales in CNS/pharma.
• Experience selling to hospitals, IDNs, and institutions.
• Familiar with pre-launch planning and early market execution.
• Knowledge of formulary access strategies and market penetration.
• Proven track record of meeting quota and territory goals.

Responsibilities

• Execute territory business plans to achieve and exceed sales goals.
• Develop and maintain strong relationships with healthcare providers and key stakeholders.
• Drive product adoption through effective customer engagement and education.
• Navigate complex patient pathways and support access to therapy.
• Partner with Market Access, Strategic Accounts, Patient Services, and Medical teams to optimize outcomes.
• Support launch execution, including pre-launch planning and post-launch adoption strategies.

Skills

Direct sales CNS/pharma

Hospital/IDN sales

Formulary access strategies

Product launch experience

Territory management

Job description

Praxis Precision Medicines, Inc. is seeking six Account Specialists to cover the Ann Arbor Region in a remote US role.

Successful candidates will engage healthcare providers, support launches, and drive access to our CNS-focused therapies across the territory. You will collaborate with Market Access, Patient Services, and Medical teams to optimize patient outcomes, navigate complex access pathways, and deliver on commercial objectives while maintaining extensive product and disease-state